Stem Cells: A Beacon of Hope in Combating COVID-19 and Cytokine Storm

Authored by renowned experts Yogesh Kumar Verma, Neeraj Kumar Satija, Pawan Kumar Raghav, Nishant Tyagi, and Subodh Kumar, this comprehensive publication delves into the mechanistic insights of stem cells in combating the COVID-19 outbreak and other pathologies triggered by cytokine storms.

The last decade has witnessed a surge in novel diseases, including mucormycosis, Zika virus, and H1N1 influenza virus, among others. A common thread among these diseases is the induction of cytokine storms, which are primarily responsible for morbidity and mortality.

The Emergence of Stem Cell Therapy

Stem cell therapy has emerged as a promising treatment for viral diseases, including but not limited to COVID-19. Clinical trials have demonstrated faster recovery in patients with COVID-19 complications following mesenchymal stem cells therapy, attributed to decreased cytokine levels, anti-viral effects, and regeneration of infected tissues.

Key Takeaways

• Evaluates the role of Mesenchymal Stem Cells (MSCs) in combating cytokine storms
• Assesses the challenges in COVID-19 therapy and how they can be countered using stem cells
• Examines the risk of opportunistic infections post COVID-19
• Delves into the therapeutic aspects of the novel coronavirus

This publication provides a detailed understanding of the novel coronavirus, with a focus on its therapeutic aspects.

Publication Details

Published by Academic Press, this book is set to release on November 29, 2023. Written in English, it will be available in digital format, complete with sticky notes on Kindle Scribe.